HeadWise cover image

OnabotulinumtoxinA for Migraine: What You Need to Know

HeadWise

00:00

Exploring the Effectiveness of OnabotulinumtoxinA for Chronic Migraine Treatment

This chapter examines the role of OnabotulinumtoxinA in treating chronic migraines, focusing on its FDA approval and supporting research that showcases reduced headache frequency. It also addresses the interplay between Onabot and CGRP monoclonal antibodies, highlighting potential benefits of their combined use in enhancing patient outcomes.

Play episode from 02:14
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app